Argenx Se (ARGX) Stock Forecast & Price Target

Compare

772 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARGX Analyst Ratings

Strong Buy

17 Buy

2 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Argenx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$1,036.18

▲(46.18% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $1,036.18 with a high forecast of $1,247.00 and a low forecast of $867.00. The average price target represents a 46.18% change from the last price of $708.85.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"541":"$541","1248":"$1,248","717.75":"$717.8","894.5":"$894.5","1071.25":"$1,071.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1247,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.25K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1036.18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.04K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":867,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$867.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[541,717.75,894.5,1071.25,1248],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,756.76,794.4707692307692,832.1815384615385,869.8923076923077,907.603076923077,945.3138461538462,983.0246153846153,1020.7353846153846,1058.4461538461537,1096.156923076923,1133.8676923076923,1171.5784615384614,1209.2892307692307,{"y":1247,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,756.76,778.2538461538461,799.7476923076923,821.2415384615384,842.7353846153846,864.2292307692308,885.723076923077,907.2169230769231,928.7107692307693,950.2046153846154,971.6984615384616,993.1923076923077,1014.686153846154,{"y":1036.18,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,756.76,765.24,773.72,782.2,790.68,799.16,807.64,816.12,824.6,833.08,841.56,850.04,858.52,{"y":867,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":624.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.605,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":706.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":767.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 67,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":818.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":894.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":840.95,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":835.68,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 76,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":756.76,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 69,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,247

Average Price Target$1,036

Lowest Price Target$867.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Yaron Werber

TD Cowen

$1,146

Buy

61.67%

Upside

Reiterated

03/13/26

Analysts' Top Healthcare Picks: Apellis Pharmaceuticals (APLS), Argenx Se (ARGX)

David Nierengarten

Wedbush

$1,000

Buy

41.07%

Upside

Reiterated

03/09/26

Wedbush Keeps Their Buy Rating on Argenx Se (ARGX)

Douglas Tsao

H.C. Wainwright

$940

Buy

32.61%

Upside

Reiterated

03/02/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Derek Archila

Wells Fargo

$1,317→$1,247

Buy

75.92%

Upside

Reiterated

02/27/26

Argenx price target lowered to $1,247 from $1,317 at Wells FargoArgenx price target lowered to $1,247 from $1,317 at Wells Fargo

Allison Bratzel

Piper Sandler

$1,075

Buy

51.65%

Upside

Reiterated

02/27/26

Argenx Se (ARGX) Gets a Buy from Piper Sandler

Jason Butler

Citizens JMP

$925→$944

Buy

33.17%

Upside

Reiterated

02/27/26

Argenx price target raised to $944 from $925 at CitizensArgenx price target raised to $944 from $925 at Citizens

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Neurogene (NGNE)

Sean Laaman

Morgan Stanley

$1,160→$1,230

Buy

73.52%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (NASDAQ: TRDA), Kymera Therapeutics (NASDAQ: KYMR) and Argenx Se (NASDAQ: ARGX)

Colleen M. Kusy

Robert W. Baird

$858→$867

Hold

22.31%

Upside

Reiterated

02/27/26

Argenx price target raised to $867 from $858 at BairdArgenx price target raised to $867 from $858 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$1,008

Buy

42.20%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Argenx Se (ARGX)

Alex Thompson CFA

Stifel Nicolaus

$1,248→$1,227

Buy

73.10%

Upside

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Lantheus (NASDAQ: LNTH)

Yatin Suneja

Guggenheim

$1,160→$1,120

Buy

58.00%

Upside

Reiterated

02/26/26

Argenx price target lowered to $1,120 from $1,160 at GuggenheimArgenx price target lowered to $1,120 from $1,160 at Guggenheim

Matt Phipps

William Blair

―

Buy

―

Reiterated

02/26/26

Vyvgart’s Strengthening MG Franchise and Pipeline Catalysts Support Buy Rating on Argenx

Rajan Sharma

Goldman Sachs

$905→$910

Buy

28.38%

Upside

Reiterated

02/26/26

Argenx Se (ARGX) Gets a Buy from Goldman Sachs

Tazeen Ahmad

Bank of America Securities

$1,006→$1,013

Buy

42.91%

Upside

Reiterated

02/26/26

Bank of America Securities Keeps Their Buy Rating on Argenx Se (ARGX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Yaron Werber

TD Cowen

$1,146

Buy

61.67%

Upside

Reiterated

03/13/26

Analysts' Top Healthcare Picks: Apellis Pharmaceuticals (APLS), Argenx Se (ARGX)

David Nierengarten

Wedbush

$1,000

Buy

41.07%

Upside

Reiterated

03/09/26

Wedbush Keeps Their Buy Rating on Argenx Se (ARGX)

Douglas Tsao

H.C. Wainwright

$940

Buy

32.61%

Upside

Reiterated

03/02/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Indivior (INDV)

Derek Archila

Wells Fargo

$1,317→$1,247

Buy

75.92%

Upside

Reiterated

02/27/26

Argenx price target lowered to $1,247 from $1,317 at Wells FargoArgenx price target lowered to $1,247 from $1,317 at Wells Fargo

Allison Bratzel

Piper Sandler

$1,075

Buy

51.65%

Upside

Reiterated

02/27/26

Argenx Se (ARGX) Gets a Buy from Piper Sandler

Jason Butler

Citizens JMP

$925→$944

Buy

33.17%

Upside

Reiterated

02/27/26

Argenx price target raised to $944 from $925 at CitizensArgenx price target raised to $944 from $925 at Citizens

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

02/27/26

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Neurogene (NGNE)

Sean Laaman

Morgan Stanley

$1,160→$1,230

Buy

73.52%

Upside

Reiterated

02/27/26

Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (NASDAQ: TRDA), Kymera Therapeutics (NASDAQ: KYMR) and Argenx Se (NASDAQ: ARGX)

Colleen M. Kusy

Robert W. Baird

$858→$867

Hold

22.31%

Upside

Reiterated

02/27/26

Argenx price target raised to $867 from $858 at BairdArgenx price target raised to $867 from $858 at Baird

Unknown Analyst

Jefferies

Not Ranked

Jefferies

$1,008

Buy

42.20%

Upside

Reiterated

02/27/26

Jefferies Remains a Buy on Argenx Se (ARGX)

Alex Thompson CFA

Stifel Nicolaus

$1,248→$1,227

Buy

73.10%

Upside

Reiterated

02/26/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Lantheus (NASDAQ: LNTH)

Yatin Suneja

Guggenheim

$1,160→$1,120

Buy

58.00%

Upside

Reiterated

02/26/26

Argenx price target lowered to $1,120 from $1,160 at GuggenheimArgenx price target lowered to $1,120 from $1,160 at Guggenheim

Matt Phipps

William Blair

―

Buy

―

Reiterated

02/26/26

Vyvgart’s Strengthening MG Franchise and Pipeline Catalysts Support Buy Rating on Argenx

Rajan Sharma

Goldman Sachs

$905→$910

Buy

28.38%

Upside

Reiterated

02/26/26

Argenx Se (ARGX) Gets a Buy from Goldman Sachs

Tazeen Ahmad

Bank of America Securities

$1,006→$1,013

Buy

42.91%

Upside

Reiterated

02/26/26

Bank of America Securities Keeps Their Buy Rating on Argenx Se (ARGX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months

xxx

Success Rate

13/18 ratings generated profit

Average Return

+6.55%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 72.22% of your transactions generating a profit, with an average return of +6.55% per trade.

1 Year

Thomas SmithLeerink Partners

Success Rate

24/27 ratings generated profit

Average Return

+28.23%

reiterated a buy rating 6 months ago

Copying Thomas Smith's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +28.23% per trade.

2 Years

xxx

Success Rate

26/27 ratings generated profit

Average Return

+53.87%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 96.30% of your transactions generating a profit, with an average return of +53.87% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARGX has received 69 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 1,036.18.

Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $5.64 with a range of $2.57 to $7.78. The previous quarter’s EPS was $8.02. ARGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $1.34B with a range of $1.15B to $1.44B. The previous quarter’s sales results were $2.41B. ARGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?

Based on analyst ratings, Argenx Se’s 12-month average price target is 1,036.18.

What is ARGX’s upside potential, based on the analysts’ average price target?

Argenx Se has 46.18% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARGX a Buy, Sell or Hold?

Argenx Se has a consensus rating of Strong Buy which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.

What is Argenx Se’s price target?

The average price target for Argenx Se is 1,036.18. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,247.00 ,the lowest forecast is $867.00. The average price target represents 46.18% Increase from the current price of $708.85.

What do analysts say about Argenx Se?

Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of ARGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Argenx Se (ARGX) Stock Forecast & Price Target

ARGX Analyst Ratings

ARGX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Argenx Se

ARGX Analyst Recommendation Trends

ARGX Financial Forecast

ARGX Earnings Forecast

ARGX Sales Forecast

ARGX Stock Forecast FAQ

Detailed List of Analyst Forecasts